Abstract: A modular cabinet for use with a gaming device. The gaming device modular cabinet includes a display cabinet removably connected to a component cabinet by a locking mechanism. The cabinets are preferably made of rolled steel, where the display cabinet is adapted to receive at least the display, while the component cabinet is adapted to receive the components for the gaming device other than the display. In a preferred embodiment, the present invention includes laminated side panels connected to the display and component cabinets. The gaming device further includes a monitor cover removably connected to the display cabinet.

Abstract: A gaming device having a card management system which is operable to manage a plurality of circulating data cards. The gaming device, in one embodiment, preferably includes a card read-write device for reading data cards, one or more card holders for holding a plurality of data cards and one or more card transporters for moving data cards to and from the card holders. The gaming device processor preferably uses the read-write device to reset or change data on data cards. The present invention increases the convenience and efficiency for playing and managing gaming devices.

Abstract: A gaming device having an extendable button and a co-molded switch. The apparatus and method includes inserting a pushbutton switch and connection cord into a mold. A first portion is formed around the cord by injecting a first material onto the cord proximate the button. A second portion is formed around the cord by injecting a second material onto the mold proximate the first portion.

Abstract: A gaming device including a mechanical display which includes a housing, a symbol display mechanism rotatably connected to the housing, a plurality of independent symbol display members including at least one symbol rotatably connected to the symbol display mechanism and a pivoting symbol indicator connected to the center of the symbol display mechanism. Upon a triggering event in a game, the symbol display mechanism rotates relative to the housing and each of the symbol display members rotate relative to the symbol display mechanism. The pivoting symbol indicator pivots downward towards one of the symbol display members to indicate the symbol on the symbol display member. The mechanical display may be used in a primary game, a secondary game or any suitable type of game.

Abstract: A gaming device wherein the success or failure of a current selection directly affects the player's chances for success in a later selection and the player's chances for obtaining the highest bonus award possible.

Abstract: A disclosed player tracking unit provides a display, a wireless interface device designed or configured to communicate with a portable wireless headset, and a logic device designed or configured to communicate with the display, the wireless interface device, a master gaming controller that controls a game played on a gaming machine, and a player tracking server. The logic device can further communicate with the portable wireless headset using the wireless interface device. The portable wireless headset can include one or more earpieces configured to be worn by a player. Various messages, alerts, music, etc. can be sent from the player tracking unit to the portable wireless headset.

Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.

Abstract: The present invention provides compositions, therapeutic combinations and methods including: (a) at least one HM74 or HM74A agonist and (b) at least one substituted azetidinone or substituted &bgr;-lactam sterol absorption inhibitor which can be useful for treating vascular conditions, diabetes, obesity and lowering plasma levels of sterols.

Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.

Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.

Abstract: The present invention provides an isolated mammalian histamine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by histamine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor.

Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.

Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.

Abstract: The present invention relates to the agonist properties of vMIP-I for the chemokine receptor CCR8 as expressed on Th2 cells. Methods of modulating a physiological signal specific to Th2 cells comprising contacting these cells with vMIP-I, agonists and antagonists thereof are disclosed. Methods for treating disease using CCR8 antagonists are also provided. The modulation of the Th2 cell populations through the vMIP-I/CCR8 interaction provides a new means for diagnosing and treating specific disease states and immunologic conditions.

Abstract: Nucleic acids encoding mammalian, e.g., rodent, IL-1&dgr;, IL-1&egr;, purified IL-1&dgr; and IL-1&egr; proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.

Abstract: The present invention provides an isolated mammalian adenosine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by adenosine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian adenosine receptor.

Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding said chemokines or receptors. Methods of using said reagents and diagnostic kits are also provided.

Abstract: The present invention provides an isolated mammalian histamine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by histamine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor.

Abstract: The present invention relates to the agonist properties of vMIP-I for the chemokine receptor CCR8 as expressed on Th2 cells. Methods of modulating a physiological signal specific to Th2 cells comprising contacting these cells with vMIP-I, agonists and antagonists thereof are disclosed. Methods for treating disease using CCR8 antagonists are also provided. The modulation of the Th2 cell populations through the vMIP-I/CCR8 interaction provides a new means for diagnosing and treating specific disease states and immunologic conditions.

Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.